BSE Live
Dec 08, 16:01Prev. Close
355.20
Open Price
355.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 08, 15:44Prev. Close
355.40
Open Price
352.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Gufic Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 10.03 | 10.03 | 9.69 | 9.69 | 9.69 | |
| Total Share Capital | 10.03 | 10.03 | 9.69 | 9.69 | 9.69 | |
| Reserves and Surplus | 591.34 | 522.53 | 338.11 | 259.42 | 163.74 | |
| Total Reserves and Surplus | 591.34 | 522.53 | 338.11 | 259.42 | 163.74 | |
| Total Shareholders Funds | 601.36 | 532.56 | 347.81 | 269.12 | 173.44 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 130.50 | 153.96 | 190.68 | 47.40 | 35.43 | |
| Deferred Tax Liabilities [Net] | 7.77 | 2.06 | 0.00 | 0.19 | 1.49 | |
| Other Long Term Liabilities | 24.97 | 16.53 | 21.17 | 5.33 | 7.82 | |
| Long Term Provisions | 17.49 | 15.38 | 13.29 | 12.39 | 10.23 | |
| Total Non-Current Liabilities | 180.73 | 187.93 | 225.14 | 65.30 | 54.96 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 179.88 | 163.07 | 120.73 | 13.84 | 16.32 | |
| Trade Payables | 158.75 | 166.27 | 130.26 | 140.95 | 113.03 | |
| Other Current Liabilities | 44.53 | 37.97 | 32.97 | 27.31 | 29.74 | |
| Short Term Provisions | 4.38 | 4.74 | 4.24 | 4.87 | 4.57 | |
| Total Current Liabilities | 387.53 | 372.05 | 288.21 | 186.98 | 163.66 | |
| Total Capital And Liabilities | 1,169.63 | 1,092.54 | 861.16 | 521.40 | 392.06 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 499.65 | 153.27 | 158.89 | 114.56 | 99.52 | |
| Intangible Assets | 6.34 | 5.62 | 0.68 | 0.61 | 0.45 | |
| Capital Work-In-Progress | 21.82 | 307.06 | 169.59 | 40.87 | 13.40 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 527.81 | 465.95 | 329.16 | 156.04 | 113.37 | |
| Non-Current Investments | 2.81 | 1.79 | 0.78 | 0.01 | 0.01 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.97 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.22 | 0.41 | 0.34 | 0.24 | 11.59 | |
| Other Non-Current Assets | 15.02 | 23.91 | 65.80 | 44.36 | 6.51 | |
| Total Non-Current Assets | 545.85 | 492.07 | 397.05 | 200.65 | 131.48 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 216.87 | 200.48 | 183.46 | 115.57 | 94.40 | |
| Trade Receivables | 314.61 | 329.94 | 205.47 | 151.55 | 124.50 | |
| Cash And Cash Equivalents | 28.21 | 13.47 | 46.69 | 26.57 | 13.18 | |
| Short Term Loans And Advances | 0.32 | 0.37 | 0.20 | 0.38 | 0.25 | |
| OtherCurrentAssets | 63.77 | 56.20 | 28.29 | 26.68 | 28.25 | |
| Total Current Assets | 623.78 | 600.47 | 464.11 | 320.75 | 260.58 | |
| Total Assets | 1,169.63 | 1,092.54 | 861.16 | 521.40 | 392.06 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 6.89 | 11.80 | 27.87 | 100.51 | 16.20 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 216.30 | 204.83 | 271.56 | 230.04 | 109.74 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 159.72 | 91.05 | 86.03 | 73.16 | 56.13 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.53 | 5.53 | 5.53 | 5.53 | 5.53 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 2.81 | 1.79 | 0.78 | 0.01 | 0.01 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y
04.12.2025
Gufic Bio Consolidated September 2025 Net Sales at Rs 237.05 crore, up 16.1% Y-o-Y
13.06.2025
Gufic Bio Standalone March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
05.06.2025
Gufic Bio Consolidated March 2025 Net Sales at Rs 205.02 crore, up 5.14% Y-o-Y
11.03.2025
Gufic Bio Consolidated December 2024 Net Sales at Rs 207.79 crore, up 2.98% Y-o-Y